A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer
Authors:
- 11 November 2026
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 53 (1)
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi studyGynecologic Oncology, 2023
- Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian CancerJAMA Surgery, 2022
- Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysisGynecologic Oncology, 2013
- Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 2008
- A solution to the problem of separation in logistic regressionStatistics in Medicine, 2002
- Interval estimation for the difference between independent proportions: comparison of eleven methodsStatistics in Medicine, 1998
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORSStatistics in Medicine, 1996
- Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis1996
- Index for rating diagnostic testsCancer, 1950